Tennessee Hemp Operators Get Temporary Relief from Planned

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
149
Tennessee Hemp Operators Get Temporary Relief from Planned Product Ban

The hemp industry in Tennessee has grown significantly since the legislature first approved the possession, production and sale of this crop in 2019. Recent survey data shows that the state’s hemp industry rakes in between $280-$560 million in sales annually. Hemp is differentiated from marijuana by its concentration of delta-9 THC, a potent cannabinoid that triggers the release of dopamine in the brain, inducing a high.

At the federal and state levels, marijuana with a concentration of less than 0.3% delta-9 THC is defined as legal hemp. Plants with higher THC concentrations are classified as marijuana, which is illegal to possess, sell or grow in the state of Tennessee. Late last year, the state’s agriculture department formulated regulations that would make it compulsory for all hemp products to be tested for delta-9 THC, particularly that which is produced from THCA.

THCA is a non-psychoactive cannabinoid that is found in the marijuana plant. When this compound is smoked or heated, it converts into delta-9 THC, which is illegal in Tennessee in high amounts. In addition to this, the regulations would impose license requirements, age restrictions and taxes on players in the state’s nascent hemp industry.

Naturally, the regulations were disputed, with the Tennessee Healthy Alternatives Association and the Tennessee Growers Coalition arguing that this would lead to a ban of products that hadn’t been criminalized by the General Assembly.

CBD and THCA are legally sold in edibles as well as smokable flowers in the state. The industry groups added that a huge share of the market would be affected if the rules went into effect, with many businesses downsizing or worse, laying off employees. Furthermore, they claimed that the department had overstepped its authority on the matter.

Attorneys of the state disputed these claims, asserting that the department of agriculture was acting lawfully when it imposed limits on some chemicals found in hemp.

This dispute led to the issuance of a temporary injunction by Davidson County Chancellor I’Ashea Myles, preventing the regulations from taking effect on December 26th. The injunction is in effect until the trial, which is slated for June 5th.

These developments come after legislators in the state tried to ban all products derived from hemp in 2022 but failed to garner the votes needed to approved the bill. Following this setback, legislators decided to focus on regulating the hemp industry. This began with the approval of a measure that would ban the sale of hemp-derived cannabinoid products to individuals aged less than 21.

Other hemp industry actors like Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) operating in other markets are likely to welcome the reprieve provided by the court in Tennessee since it would give all parties time to prepare their case and let the court decide one way or the other.

NOTE TO INVESTORS: The latest news and updates relating to Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) are available in the company’s newsroom at https://cnw.fm/SFWJ

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Software Effective (SFWJ) Stock Research Links

SFWJ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OPay's IPO Launches: A $19 ADS Debut on NYSE

Updated Category News Views 28

Navigating the Waters of OPay's IPO Ah, the sweet smell of an IPO in the morning. Kicks off like a shot of espresso, doesn't it? Well, OPay's got coffee beans roasting with their IPO splash today. The digital financial platform, which has been shaking up the markets in Nigeria and beyond, announced they're selling 16 million American Depositary Shares (ADSs) at $19 a pop....

Continue Reading
Deciding Between Root Canal or Tooth Extraction

Updated Category News Views 89

The Battle Between Saving and Extracting Teeth No one really talks about teeth as if they hold the keys to happiness, but let’s face it, the difference between chewing a juicy steak and wincing with every bite can be the fate of a single tooth. Dr. Carey Norton from Dacula Family Dentistry breaks down when a root canal can be an oasis of hope and when extraction is the...

Continue Reading
Viatris Bids for Pacira: Strategic Healthcare Move

Updated Category News Views 41

Viatris Takes Strategic Step With Pacira Acquisition You ever notice how in the pharmaceutical games, it's not always the pills but the strategic moves that make the money? Viatris Inc., the global healthcare heavyweight, has just rolled the dice. They've initiated a tender offer to acquire Pacira BioSciences, a player in the non-opioid pain management market. Here's the...

Continue Reading
JAS Hits Top 1% in EcoVadis Sustainability Rankings

Updated Category News Views 101

A Platinum Performance in EcoVadis Ratings JAS Worldwide, hustling around in the logistics and supply chain sector, just nailed a spot in the much-coveted top 1% bracket for sustainability according to EcoVadis. We’re talking about a company that’s not only steering the mammoth ships of logistics but now it’s also wearing sustainability like a crown. This...

Continue Reading
MadaLuxe Snags DUXIANA in North American Expansion

Updated Category News Views 60

MadaLuxe's Bold Step into Luxury Sleep Here's a twist in the luxury game: MadaLuxe Group has grabbed the reins of DUXIANA's North American distribution business. If you haven't run into this iconic Swedish brand yet, it's been peddling high-end beds for a good century. Yep, 100 years of Swedish craftsmanship now in the pocket of MadaLuxe. They didn't spill any beans on...

Continue Reading
TDS and Array Set for Q3 Results Amid Market Curiosity

Updated Category News Views 30

The Anticipation Builds for TDS and Array's Q3 Results Financial markets are buzzing like a caffeine-fueled trading floor about the upcoming third quarter results from Telephone and Data Systems, Inc. (NYSE: TDS) and its partner in digital endeavors, Array Digital Infrastructure, Inc. (NYSE: AD). Set to go live with their numbers on November 6, 2026, these companies are...

Continue Reading
Bybit Unveils Platform Vision at HK FinTech Week

Updated Category News Views 52

Bybit's Strategic Participation at HK FinTech Week Here’s what’s got everyone buzzing: Bybit is stepping onto the big stage at the Hong Kong FinTech Week 2026. We're talking about the crème de la crème of fintech gatherings, where the sharpest minds of the financial world mingle, munch, and strategize under the buzzing neon of Hong Kong. Bybit's involvement is no...

Continue Reading
Royal Princess Docks New Features for Onboard Experience

Updated Category News Views 89

Royal Princess Sets Sail Refreshed Ever imagine what goes on behind the scenes of a full-blown ship makeover? Well, the Royal Princess just strutted out of a two-week stint in the drydock like a queen in a new frock. This ain't just slapping a fresh coat of paint on the hull. We're talking the debut of the Sanctuary Collection, a whole new gamut of spots for guests to wet...

Continue Reading
WesternU's Big Night: Boosting Lebanon’s Health Hub

Updated Category News Views 16

Building Bridges in Healthcare: WesternU's Strategic Move Heck, you know it's the real deal when a university throws a dinner party to celebrate partnerships. Western University of Health Sciences (WesternU) decided to clink glasses with Lebanon community leaders, hammering home the importance of their collaboration on October 6, 2026. Now, don't think this was just some...

Continue Reading
European Doctors Explore Chinese Aesthetic Innovations

Updated Category News Views 39

Pioneering Exchange in Regenerative Aesthetics Ever seen European doctors flocking to China to learn about beauty techniques? That's the scene as aphranel®, the brainchild of MOYOM Biotech, ushers in a week-long clinical exchange under 'The Norns' Weave.' The whole deal aims to unravel how Chinese practices could shape Europe's aesthetic landscape. Yep, it's all about...

Continue Reading

Top 5 Most Recently Viewed Articles

Hematology Analyzers Market Growth Projections to 2034

Updated Category News Views 173

Hematology Analyzers Market Growth Potential The global hematology analyzers market is witnessing impressive growth, anticipated to reach approximately USD 7.28 billion by 2034 from a previous valuation of USD 4.08 billion in 2024. This growth, representing an impressive CAGR of 5.97%, can be attributed to several key factors including the rise in blood-related disorders,...

Continue Reading
Interlune Secures $4.8 Million Grant for Lunar Research Facility

Updated Category News Views 677

Interlune Announces New Research Facility in Texas Interlune, a pioneering natural resources company, has officially disclosed its ambitious project of creating a Lunar Regolith Simulant Center of Excellence. With the support of a generous grant of up to $4.84 million from the Texas Space Commission (TSC), Interlune is set to establish a facility dedicated to the...

Continue Reading
Protiviti's Leadership Shifts Mark Next Growth Phase

Updated Category News Views 45

Leadership Shake-ups at Protiviti: A Strategic Move The winds of change are blowing at Protiviti, Robert Half’s consulting arm. Come January 1, 2027, Joe Tarantino, the seasoned skipper of this ship, is stepping away from the helm. After pouring two decades of leadership into the firm, he’s sliding sideways into a senior managing director role. Meanwhile, Cory...

Continue Reading
Clarivate Reports Disappointing Q3 2024 Financial Performance

Updated Category News Views 150

Clarivate Releases Third Quarter Financial Results Clarivate Plc (NYSE: CLVT), a prominent global provider of transformative intelligence, has released its financial results for the third quarter of 2024, revealing unsatisfactory performance. The company reported total revenues of $622.2 million, indicating a decrease of 3.9% compared to the previous year. The decline in...

Continue Reading
Stride's Legal Troubles: Unveiling the Truth Behind Its Stock Drop

Updated Category News Views 116

Understanding Stride's Legal Challenges Marketing its educational services, Stride, Inc. (NYSE: LRN) is presently embroiled in serious legal issues that stem from claims of securities fraud. Investors have been alarmed by the allegations that Stride misrepresented key operational figures, particularly regarding enrollment statistics. The ongoing class action lawsuit...

Continue Reading